Every case and control participant underwent the following steps
Determination of BMI.[34 (link)] Selected cases and controls included obese and nonobese participants
Evaluation for the presence of MS whose criteria were identified according to the National Cholesterol Education Program Adult Treatment Panel III[35 (link)]
Detection of PPAR-γ gene polymorphism by restriction fragment length polymorphism polymerase chain reaction (PCR).